Stock Scorecard
Stock Summary for Madrigal Pharmaceuticals Inc (MDGL) - $300.16 as of 7/1/2025 8:03:14 PM EST
Total Score
8 out of 30
Safety Score
50 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MDGL
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MDGL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MDGL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MDGL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MDGL (50 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for MDGL
Financial Details for MDGL
Company Overview |
|
|---|---|
| Ticker | MDGL |
| Company Name | Madrigal Pharmaceuticals Inc |
| Country | USA |
| Description | Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 300.16 |
| Price 4 Years Ago | 84.74 |
| Last Day Price Updated | 7/1/2025 8:03:14 PM EST |
| Last Day Volume | 216,941 |
| Average Daily Volume | 318,117 |
| 52-Week High | 377.46 |
| 52-Week Low | 200.63 |
| Last Price to 52 Week Low | 49.61% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.32 |
| Sector PE | 40.59 |
| 5-Year Average PE | -29.59 |
| Free Cash Flow Ratio | 36.30 |
| Industry Free Cash Flow Ratio | 17.78 |
| Sector Free Cash Flow Ratio | 32.59 |
| Current Ratio Most Recent Quarter | 5.91 |
| Total Cash Per Share | 8.27 |
| Book Value Per Share Most Recent Quarter | 32.03 |
| Price to Book Ratio | 9.40 |
| Industry Price to Book Ratio | 34.87 |
| Sector Price to Book Ratio | 30.79 |
| Price to Sales Ratio Twelve Trailing Months | 21.04 |
| Industry Price to Sales Ratio Twelve Trailing Months | 122.74 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.45 |
| Analyst Buy Ratings | 10 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 22,203,300 |
| Market Capitalization | 6,664,542,528 |
| Institutional Ownership | 108.17% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 10.80% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -24.69% |
| Reported EPS 12 Trailing Months | -17.84 |
| Reported EPS Past Year | -3.32 |
| Reported EPS Prior Year | -22.11 |
| Net Income Twelve Trailing Months | -391,589,000 |
| Net Income Past Year | -465,892,000 |
| Net Income Prior Year | -373,630,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | -57.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 183,646,000 |
| Total Cash Past Year | 100,019,000 |
| Total Cash Prior Year | 99,915,000 |
| Net Cash Position Most Recent Quarter | 65,641,000 |
| Net Cash Position Past Year | -17,550,000 |
| Long Term Debt Past Year | 117,569,000 |
| Long Term Debt Prior Year | 115,480,000 |
| Total Debt Most Recent Quarter | 118,005,000 |
| Equity to Debt Ratio Past Year | 0.87 |
| Equity to Debt Ratio Most Recent Quarter | 0.86 |
| Total Stockholder Equity Past Year | 754,383,000 |
| Total Stockholder Equity Prior Year | 405,333,000 |
| Total Stockholder Equity Most Recent Quarter | 710,637,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -401,411,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -18.08 |
| Free Cash Flow Past Year | -457,034,000 |
| Free Cash Flow Prior Year | -325,709,000 |
Options |
|
| Put/Call Ratio | 0.73 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.77 |
| MACD Signal | -1.87 |
| 20-Day Bollinger Lower Band | 262.95 |
| 20-Day Bollinger Middle Band | 309.68 |
| 20-Day Bollinger Upper Band | 356.40 |
| Beta | -1.08 |
| RSI | 59.79 |
| 50-Day SMA | 292.01 |
| 150-Day SMA | 233.88 |
| 200-Day SMA | 195.12 |
System |
|
| Modified | 7/1/2025 4:52:40 AM EST |